Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
P/E ratio for Baxter (BAX)
P/E ratio as of June 2024 (TTM): 6.53
According to Baxter's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 6.5293. At the end of 2022 the company had a P/E ratio of -10.6.
P/E ratio history for Baxter from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -10.6 | -131.47% |
| 2021 | 33.5 | -9.74% |
| 2020 | 37.1 | -12.93% |
| 2019 | 42.7 | 93.81% |
| 2018 | 22.0 | -55.05% |
| 2017 | 49.0 | 901.7% |
| 2016 | 4.89 | -77.3% |
| 2015 | 21.5 | 148.79% |
| 2014 | 8.65 | -15.24% |
| 2013 | 10.2 | 19% |
| 2012 | 8.58 | 24.82% |
| 2011 | 6.87 | -39.5% |
| 2010 | 11.4 | 29.75% |
| 2009 | 8.76 | -2.84% |
| 2008 | 9.01 | -24.26% |
| 2007 | 11.9 | 1.52% |
| 2006 | 11.7 | -11.17% |
| 2005 | 13.2 | -55.7% |
| 2004 | 29.8 | 169.46% |
| 2003 | 11.1 | -7.47% |
| 2002 | 11.9 | -53.46% |
| 2001 | 25.7 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 29.6 | 353.84% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 36.7 | 461.86% | 🇺🇸 USA |
 Becton Dickinson BDX | 40.9 | 525.81% | 🇺🇸 USA |
 Boston Scientific BSX | 91.5 | 1,300.81% | 🇺🇸 USA |
 Stryker Corporation SYK | 50.0 | 665.82% | 🇺🇸 USA |
 Cardinal Health CAH | 96.7 | 1,381.67% | 🇺🇸 USA |
 ICU Medical
ICUI | -51.3 | -884.96% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 24.9 | 281.57% | 🇺🇸 USA |
 Owens & Minor
OMI | -13.4 | -304.80% | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.